Janux Therapeutics Cash Flow Statement 2019-2024 | JANX

Fifteen years of historical annual cash flow statements for Janux Therapeutics (JANX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-58.29$-63.06$-32.67$-6.78$-4.00
$-5.73$-1.34$-0.06$0.01$0.01
$20.01$17.20$6.91$2.01$0.24
$14.27$15.86$6.85$2.03$0.25
$0$0$8.00$-8.00$0
$0$0$0$0$0
$0.28$-0.29$2.14$0.01$0.00
$-6.15$0.41$-4.33$7.75$0
$-6.55$4.28$8.84$0.39$-0.07
$-50.58$-42.92$-16.98$-4.37$-3.83
$-1.85$-6.45$-1.48$0$0
$0$0$0$0$0
$0$0$0$0$0
$-39.34$64.71$-339.48$0$0
$0$0$0$0$0
$-39.34$64.71$-339.48$0$0
$0$0$0$0$0
$-41.19$58.27$-340.96$0$0.00
$0$0$0$0$0
$0$0$0$2.50$4.00
$0$0$0$2.50$4.00
$59.55$0.50$1.81$0.07$0
$59.55$0.50$182$9.02$0
$0$0$0$0$0
$0$0$204$0$0
$59.55$0.50$387$11.52$4.00
$-32.22$15.84$28.59$7.16$0.17
$20.01$17.20$6.91$0.07$0.01
$0$0$0$0$0